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Kawasaki disease (KD) was first described in Japan in
1967 by Tomisaku Kawasaki [1]. It is an acute, systemic,
self-limited vasculitis, whose targets are medium
diameter vessels in each organ and apparatus. It is a vas-
culitis of unknown aetiology, probably multifactorial,
that occurs predominantly in infants and young chil-
dren. The most important complications are coronary
arteries aneurysms or ectasia, that develop in 15% to
25% of untreated patients, but only in 5% of patients
treated with immunoglobulins within ten days following
onset of fever [2,3].
Typical Kawasaki disease is characterized by signs and
symptoms which are defined as “diagnostic clinical cri-
teria”, and are:
– ≥5 days of fever
– bilateral non-exudative conjunctivitis
– erythema of the lips and oral mucosa
– changes in the extremities (i.e. erythema of the
palms and soles or firm, sometimes painful indura-
tion of the hands or feet, erythema of the perineal
region)
– cutaneous rash
– cervical lymphadenopathy [3,4].
Diagnosis of KD is based on clinical criteria [3,4]:
there are neither typical clinical features nor diagnostic
tests. An increasing number of children is reported in
literature, having coronary artery aneurysms or ectasia,
but who do not fulfill all diagnostic criteria. These cases
are defined as incomplete KD and atypical KD.
Typical KD is diagnosed if:
– fever ≥ 5 days associated with ≥ 4 diagnostic cri-
teria, even before performing echocardiography
– fever ≥ 5 days associated with < 4 diagnostic cri-
teria and possible coronary arteries lesions
– fever at fourth day with ≥ 4 diagnostic criteria and
possible coronary arteries lesions.
Finally, other clinical findings may be present in KD:
– Cardiac: coronaritis, pericarditis, myocarditis,
endocarditis, mitral regurgitation, aortic and tricuspi-
dal regurgitation (in the acute phase), aortic dilata-
tion (in the later phase), cardiac failure, shock,
arrhythmia, coronary artery involvement (in the sub
acute phase)
– Vascular: Raynaud phenomenon, peripheral
gangrene
– Joints: arthritis or arthralgia
– Nervous System: irritability, aseptic meningitis,
sensor-neural hearing loss, transient unilateral per-
ipheral facial nerve palsy
– Gastrointestinal: diarrhoea, vomiting, abdominal
pain, acute surgical abdomen, hepatic enlargement
and jaundice, acute acalculous distention of the gall-
bladder (hydrops)
– Urinary: aseptic pyuria, urethritis, testicular
swelling
– Skin: erythema and induration at the site of a pre-
vious vaccination with Bacille Calmette-Guérin, Beau
lines
– Respiratory: cough, rhinorrea, pulmonary nodules
and infiltrates.
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